These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. Lee R; Kavoussi RJ; Coccaro EF Int Clin Psychopharmacol; 2008 Nov; 23(6):337-41. PubMed ID: 18854722 [TBL] [Abstract][Full Text] [Related]
5. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later. Janowsky DS; Barnhill LJ; Khalid AS; Davis JM J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207 [TBL] [Abstract][Full Text] [Related]
7. Psychopharmacologic treatment of pathologic aggression. Fava M Psychiatr Clin North Am; 1997 Jun; 20(2):427-51. PubMed ID: 9196923 [TBL] [Abstract][Full Text] [Related]
8. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Coccaro EF; Kavoussi RJ Arch Gen Psychiatry; 1997 Dec; 54(12):1081-8. PubMed ID: 9400343 [TBL] [Abstract][Full Text] [Related]
9. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. Zanarini MC; Frankenburg FR; Parachini EA J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677 [TBL] [Abstract][Full Text] [Related]
10. Fluoxetine treatment of depression in mentally retarded adults. Howland RH J Nerv Ment Dis; 1992 Mar; 180(3):202-5. PubMed ID: 1588340 [TBL] [Abstract][Full Text] [Related]
11. Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial. Constantino JN; Liberman M; Kincaid M J Child Adolesc Psychopharmacol; 1997; 7(1):31-44. PubMed ID: 9192540 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. Coccaro EF; Lee RJ; Kavoussi RJ J Clin Psychiatry; 2009 Apr; 70(5):653-62. PubMed ID: 19389333 [TBL] [Abstract][Full Text] [Related]
13. Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability. Branford D; Bhaumik S; Naik B J Intellect Disabil Res; 1998 Aug; 42 ( Pt 4)():301-6. PubMed ID: 9786445 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. Judge R; Parry MG; Quail D; Jacobson JG Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584 [TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder. Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Vielma W; Montes C; Pumarino L; Roa N Actas Esp Psiquiatr; 2007; 35(6):387-92. PubMed ID: 17597424 [TBL] [Abstract][Full Text] [Related]
16. Sertraline response in adults with mental retardation and autistic disorder. Hellings JA; Kelley LA; Gabrielli WF; Kilgore E; Shah P J Clin Psychiatry; 1996 Aug; 57(8):333-6. PubMed ID: 8778118 [TBL] [Abstract][Full Text] [Related]
17. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: a preliminary study. Markowitz PI J Clin Psychopharmacol; 1992 Feb; 12(1):27-31. PubMed ID: 1552036 [TBL] [Abstract][Full Text] [Related]
18. Serotonin function and antiaggressive response to fluoxetine: a pilot study. Coccaro EF; Kavoussi RJ; Hauger RL Biol Psychiatry; 1997 Oct; 42(7):546-52. PubMed ID: 9376450 [TBL] [Abstract][Full Text] [Related]
19. Use of fluoxetine to treat dominance aggression in dogs. Dodman NH; Donnelly R; Shuster L; Mertens P; Rand W; Miczek K J Am Vet Med Assoc; 1996 Nov; 209(9):1585-7. PubMed ID: 8899022 [TBL] [Abstract][Full Text] [Related]
20. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. New AS; Buchsbaum MS; Hazlett EA; Goodman M; Koenigsberg HW; Lo J; Iskander L; Newmark R; Brand J; O'Flynn K; Siever LJ Psychopharmacology (Berl); 2004 Nov; 176(3-4):451-8. PubMed ID: 15160265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]